Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1412-1421
JournalDiabetologia
Volume59
Issue number7
DOIs
Publication statusPublished - Jul 2016

Cite this